Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Quansheng Lv"'
Autor:
Kangkang Lv, Bo Hu, Mingzhu Xu, Li Wan, Ziqi Jin, Mimi Xu, Yuanyuan Du, Kunpeng Ma, Quansheng Lv, Yang Xu, Lei Lei, Huanle Gong, Haiyan Liu, Depei Wu, Yuejun Liu
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-15 (2022)
Abstract Background Chronic graft-versus-host disease (cGVHD) remains a major complication during the late phase of allogeneic hematopoietic stem cell transplantation (allo-HSCT). IL-39, a newly described pro-inflammatory cytokine belonging to the IL
Externí odkaz:
https://doaj.org/article/a7f8bf0686d447d8a7ed9fc95b7a9dc4
Autor:
Jingting Jiang, Binfeng Lu, Quansheng Lv, Min Yang, Xichao Dai, Wen Wen, Mingfen Sun, Xiao Zheng, Bin Xu, Yibei Zhu, Changping Wu, Lujun Chen, Liangrong Shi
Purpose: Radiofrequency ablation (RFA) has been shown to elicit tumor-specific T-cell immune responses, but is not sufficient to prevent cancer progression. Here, we investigated immune-suppressive mechanisms limiting the efficacy of RFA.Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5463f34700f23e761bf67a3b6e00e942
https://doi.org/10.1158/1078-0432.c.6523718
https://doi.org/10.1158/1078-0432.c.6523718
Autor:
Jingting Jiang, Binfeng Lu, Quansheng Lv, Min Yang, Xichao Dai, Wen Wen, Mingfen Sun, Xiao Zheng, Bin Xu, Yibei Zhu, Changping Wu, Lujun Chen, Liangrong Shi
Supplemental figure 1. Patient cohort and study design. Supplemental Figure 2. Immunochemical staining of PD-L1 antibody (1:500, clone: SP142) on the paraffin-embedded human melanoma and placenta tissues. Supplemental Figure 3. RFA of colorectal live
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f7d8ad642f9161eefed172a9f613f0
https://doi.org/10.1158/1078-0432.22457843.v1
https://doi.org/10.1158/1078-0432.22457843.v1
Autor:
Xiang Zhang, Yuqing Tu, Juan Shen, Yufeng Feng, Houshi Ma, Lian Bai, Xiaoli Li, Zhihong Lin, Lijun Dai, Feiran Gong, Tianyu Lu, Jiazi Zhou, Hanqing Chen, Quansheng Lv, Ziling Zhu, Changgeng Ruan
Publikováno v:
Leukemialymphoma. 63(11)
Leukapheresis is an effective adjuvant therapy for leukemia patients with hyperleukocytosis, but few studies have reported recent data with modern modalities and comparisons among different leukemia types. We conducted a retrospective study on leukap
Autor:
Bing-Yu Shi, Quansheng Lv, Hanqing Chen, Wenjing Miao, Baoquan Song, Yue Han, Mingqing Zhu, Qi Wan, Leisheng Zhang, Depei Wu
Publikováno v:
Thrombosis and haemostasis. 121(4)
Reduced megakaryocyte (MK) apoptosis and insufficient platelet production play important roles in the pathogenesis of immune thrombocytopenia (ITP). The contribution of plasma-derived exosomes to the decreased platelet count in ITP has not been entir
Autor:
Rui Xia, Honghong He, Yuehua Feng, Yanzheng Gu, Xiaochen Li, Quansheng Lv, Yibei Zhu, Jingshu Ma
Publikováno v:
Journal of Interferon & Cytokine Research. 38:491-499
Interleukin-33 (IL-33) is a cytokine with pleiotropic functions in various diseases; however, its role in the antitumor immune response is still unclear. We found the expression of IL-33/ST2 in nonsmall cell lung tumor microenvironment. Furthermore,
Autor:
Hong-Rui Wang, Rui Xia, Jie Fan, Xi Yang, Xin Zhao, Wen Wen, Guangbo Zhang, Peijun Tang, Shuting Zuo, Aliyah M. Weinstein, Lindsay Stollings, Chao Feng, Xuefeng Wang, Timothy L. Denning, Shayang Zang, Walter J. Storkus, Jingting Jiang, Xiaojuan Chen, Xueguang Zhang, Quansheng Lv, Yibei Zhu, Binfeng Lu
Publikováno v:
Cancer Cell. 28:296-306
SummaryCytokines play a pivotal role in regulating tumor immunogenicity and antitumor immunity. IL-36γ is important for the IL-23/IL-17-dominated inflammation and anti-BCG Th1 immune responses. However, the impact of IL-36γ on tumor immunity is unk
Autor:
Xiao Zheng, Xichao Dai, Min Yang, Wen Wen, Mingfen Sun, Liangrong Shi, Quansheng Lv, Lujun Chen, Jingting Jiang, Changping Wu, Bin Xu, Yibei Zhu, Binfeng Lu
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(5)
Purpose: Radiofrequency ablation (RFA) has been shown to elicit tumor-specific T-cell immune responses, but is not sufficient to prevent cancer progression. Here, we investigated immune-suppressive mechanisms limiting the efficacy of RFA. Experimenta